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Abstract 
The chemokines CCL21 and CCL19, and cell bound TNF family ligand lymphotoxin beta 
(LTβ), have been associated with numerous chronic inflammatory diseases. A general role in 
chronic inflammatory diseases cannot be assumed however; in the case of allergic inflam-
matory disease, CCL21/CCL19 and LTβ have not been associated with the induction, re-
cruitment, or effector function of Th2 cells nor dendritic cells to the lung. We have exam-
ined the induction of allergic inflammatory lung disease in mice deficient in CCL21/CCL19 or 
LTβ and found that both kinds of mice can develop allergic lung inflammation. To control for 
effects of priming differences in knockout mice, adoptive transfers of Th2 cells were also 
performed, and they showed that such effector cells had equivalent effects on airway hy-
per-responsiveness in both knockout background recipients. Moreover, class II positive an-
tigen presenting cells (B cells and CD11c+ dendritic cells) showed normal recruitment to 
the peribronchial spaces along with CD4 T cells. Thus, the induction of allergic responses 
and recruitment of both effector Th2 cells and antigen presenting cells to lung peribronchial 
spaces can develop independently of CCL21/CCL19 and LTβ. 
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Introduction 
The membrane-bound cytokine lymphotoxin 
beta (LTβ) is known to be important in the early 
stages of secondary lymphoid tissue development. 
Signaling by LTα1/β2 ligands through the LTβ-R in-
duces development of the stromal cells of secondary 
lymphoid tissues [1]. The stromal cells provide or-
ganization to these lymphoid tissues in large part by 
producing the chemotactic CCR7 ligand CCL21, 
which recruits both lymphocytes and dendritic cells, 
signaling through the chemokine receptor CCR7 [2,3]. 
LTβ-deficient mice show greatly impaired immune 
responses [4-6]; likewise, immune responses are sig-
nificantly delayed in CCL21 deficient mice [7]. The 
tissue site and mechanism of induction of immune 
responses in these mutant mice remain unclear. 
Interestingly, several acute and chronic inflam-
matory diseases also appear to have a strong de-
pendence on LTβ and CCL21 during their effector 
phase. Thus, blockade of LTβ-R will significantly in-
hibit graft-versus-host-disease [8,9], experimental 
colitis [10,11], and autoimmune diabetes [12]. Simi-
larly, strong local CCL21 induction was found to be Int. J. Med. Sci. 2009, 6 
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associated with autoimmune diabetes [13], chronic 
liver inflammation [14,15], multiple sclerosis [16] and 
Experimental Autoimmune Encephalomyelitis 
[17,18], rheumatoid arthritis [19], Sjogren’s syndrome 
[20], and inflammatory skin diseases [21-25]. In addi-
tion, CCL21 appears to have a role in regulating CD4 
T cell homeostatic proliferation and effector cell de-
velopment; an excess of CCL21 was found to be suffi-
cient to drive autoimmune diabetes [26]. Most of the 
inflammatory responses described above arguably 
fall into the category of Th1-mediated effector mecha-
nisms. Moreover, they are often associated with local 
development of lymphoid follicle structures (e.g., 
Sjogren’s syndrome, rheumatoid arthritis, autoim-
mune diabetes) in a process that resembles LTβ- and 
CCL21-dependent secondary lymphoid tissue devel-
opment (“lymphoid neo-organogenesis,” [27]).   
Thus, to determine whether a similar depend-
ence on LTβ and CCL21 is present in Th2-mediated 
effector mechanisms in the lung, we studied the in-
duction of allergic lung inflammation in LTβ and 
CCL21/CCL19 deficient mice. We found that both 
kinds of mutant mice mounted normal or enhanced 
Th2 responses as measured by eosinophil recruitment 
and increased airway resistance. Recruitment of CD4 
T cells, B lymphocytes, and CD11c+ dendritic cells to 
the peribronchial space was also normal. Our results 
show that the initiation and effector phase of allergic 
lung inflammation is independent of LTβ and CCL21. 
Materials and Methods 
Mice 
LTβ knockout mice (“LTβ-KO”) backcrossed to 
C57BL/6 were kindly provided by Dr. S. A. Ne-
dospasov [1], and plt/plt (“plt” )  m u t a n t  m i c e  w h i c h  
lack expression of the CCR7 ligand chemokines 
CCL21 and CCL19 [2], backcrossed to BALB/c, were 
generously provided by Dr. A. Matsusawa. Mice 
were bred and maintained under specific patho-
gen-free conditions in accordance with NIH and in-
stitutional guidelines. 
For the adoptive transfer studies in Figure 3B, 
adoptively transferred CD4 T cells were taken from 
donors matching the genetic background of the re-
cipient. Thus, C57BL/6 mice were used as donor of 
CD4 T cells for C57BL/6 and LTβ-KO mice while plt 
recipients were injected with cells from BALB/c mice. 
Transfer recipients were 6-8 weeks old. Although the 
mutant mice studied were on two different back-
grounds, the strain specific controls (e.g., challenged 
w i t h  P B S )  w e r e  u s e d  i n  e a c h  c a s e .  I n  a d d i t i o n ,  w e  
found that control mice on C57BL/6 and BALB/c 
background strains could both be induced to develop 
robust allergic lung inflammation. 
Induction of allergic lung inflammation 
Naïve mice were injected i.p. at day 0 and day 7 
with 10 µg chicken egg ovalbumin (Sigma) in 100 µl 
of PBS mixed with 100 µl of Imject Alum (Pierce, 
Rockford, IL). One week later, immunized mice were 
challenged intra-nasally with 25 µl OVA (2 mg/ml) 
or PBS once per day for 3 consecutive days.   
For adoptive transfer experiments, naïve mice 
were injected i.p. at day 0 and day 7 with 10 µg 
chicken egg ovalbumin (Sigma) in 100 µl of PBS 
mixed with 100 µl of Imject Alum (Pierce, Rockford, 
IL). One week later, immunized mice were chal-
lenged intra-nasally with 2 5  µ l  O V A  ( 2  m g / m l )  o r  
PBS once per day for 3 consecutive days. Splenic CD4 
T cells were purified on day 14 using magnetic beads 
and were i.v. injected (5x106 cells/mouse). The phe-
notype of the donor CD4 Th2 cells was confirmed by 
real-time PCR analysis of RNA for IL-2, IL-4, IFNγ, 
and HPRT, and calculating the IL-4/IFNγ ratios. In-
tranasal challenge was performed on day 14, 15 and 
16 (days 0, 1, and 2 after transfer) as described previ-
ously [28,29]. 
T cell transfer 
Spleens were aseptically removed and single cell 
suspensions were prepared by mechanical dispersion 
according to standard procedures in Hanks' balanced 
salt solution (HBSS). CD4 T cell enriched populations 
were obtained by elimination of B cells and macro-
phages by incubating for 30 min on ice with rat anti 
mouse CD45R/B220, anti-CD8, M5/114 and F4/80 
antibodies (PharMingen, San Diego, CA). Cell sus-
pensions were then incubated for 30 min on ice under 
constant agitation with magnetic beads coated with a 
sheep anti-rat IgG covalently linked Abs (Dynabeads 
M-450, Dynal, Oslo, Norway) at a bead to cell ratio of 
20:1. Non-adherent cells were collected after the re-
moval of free and cell bound beads using a magnetic 
bead concentrator (Dynal, MPC 6). The resulting cell 
populations comprised more than 90% CD4+ cells by 
flow cytofluorometry using a FITC-labeled 
anti-mouse CD4 antibody (Pharmingen) on a FAC-
Scan flow cytometer (Becton Dickinson, Mountain 
View, CA). Five million splenic CD4 T cells from do-
nor mice were injected i.v. 
Bronchoalveolar lavage (BAL)  
BAL was performed 3 hours after the last i.n. 
challenge using 3x 1ml of RPMI 2% FCS. Cells were 
counted and resuspended at a final concentration of Int. J. Med. Sci. 2009, 6 
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5x105  cells/ml. Cytospin slides were fixed with 
methanol and stained with Diff-Quick (Fisher Scien-
tific, Pittsburgh, PA). Eosinophils, mono-
cytes/macrophages and lymphocytes were enumer-
ated based on morphology and staining and ex-
pressed as percentages of total BAL cells [28,29]. 
Histology 
Frozen lung sections were fixed in 1% forma-
mide-acetone and stained for cyanide-resistant per-
oxidase activity as previously described [28,29]. Other 
sections were stained with rat anti-mouse CD4 
(PharMingen) followed by biotin F(ab’)2 mouse 
anti-rat IgG (Jackson Immunoresearch, West Grove, 
PA) and streptavidin-FITC (Jackson). APCs, dendritic 
cells and B lymphocytes were visualized using re-
spectively M5/114, anti-CD11c and anti-B220 Abs 
(culture supernatant and PharMingen) followed by 
biotinylated secondary Ab and strepta-
vidin-rhodamine or streptavidin-FITC. For dendritic 
cells, the signal was amplified using TSA-indirect kit 
according to manufacturer’s instructions (NEN Re-
search Products, Boston, MA) and revealed by strep-
tavidin-Rhodamine (Jackson Immunoresearch). 
Airway reactivity measurements 
Airway hyper-responsiveness (AHR) to meta-
choline (Acetyl-β methylcholine chloride, Sigma) was 
assessed 24 hours after the last intranasal challenge. 
Briefly, mice were maintained inside a whole-body 
plethysmograph (Buxco, Troy, NY) capable of meas-
uring changes in airflow and trans-thoracic pressures 
and resistances [30]. After establishing a stable base-
line for total lung resistance, mice were exposed to 
aerosols of saline or metacholine in increasing con-
centrations (1 to 50 mg/ml) for 3 min. Enhanced 
pause (Penh) index values reflecting changes in the 
waveform of pressure signal from both inspiration 
and expiration combined with the timing were calcu-
lated and averaged for 3 min after each nebulization. 
Results 
Allergic lung inflammation in mutant mice 
In previous studies, it was found that robust 
lung eosinophilia could be rapidly induced in mice, 
requiring only the adoptive transfer of a small num-
ber of antigen specific Th2 cells combined with anti-
gen challenge [28, 31-33]. These results suggested that 
lung allergic inflammation was not dependent on any 
“conditioning” of the lung by antigen specific effector 
cells (e.g., expressing LTβ), prior antigen exposure, or 
the presence of allergen specific IgE. Moreover, the 
rapid kinetics of the inflammation suggested that 
presentation of antigen in the lung parenchyma 
might be sufficient to trigger the cascade of cytokines 
and chemokines necessary for tissue eosinophilia 
without involvement of draining lymphoid tissues. 
We studied the induction of lung allergic in-
flammation in mice lacking LTβ (lymphotoxin-beta 
knockout, or LTβ-KO [1]) or CCL21/CCL19 (plt mu-
tant [2]). In initial studies, control, LTβ-KO, and plt 
mutant mice were immunized with OVA according 
to a protocol previously established to induce allergic 
lung inflammation in normal mice [28,29]. Figure 1 
shows that robust lung eosinophilia was generated in 
all mice at equivalent levels (though possibly in-
creased in LTβ-KO mice), suggesting that both Th2 
priming and lung eosinophilia were not impaired by 
either the LTβ or CCL21/CCL19 defects. The histol-
ogy of eosinophil infiltration was also unaffected in 
the mutant mice, as dramatic peribronchial and 
perivascular infiltration was produced in all mice 
(Figure 2). 
 
 
 
 
 
 
 
 
 
Figure 1: Eosinophilia in BAL: C57BL/6J (white bars), 
LTβ-KO (black bars) and plt/plt mice (grey bars), were 
immunized and challenged i.n. with OVA as described in 
material and methods section. Three hours after the last i.n. 
injection lung cells were harvested by lavage, counted and 
submitted to cytospin for analysis of the composition of the 
BAL. Control C57BL/6J mice (hatched bars) were not 
immunized but were challenged i.n. with OVA. Results 
summarize 4 independent experiments with 3 mice per 
group (12 mice total for each condition). Int. J. Med. Sci. 2009, 6 
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Figure 2: Histology of lung infiltrates: C57BL/6J 
mice (A, B), LTβ-KO (C) and plt/plt mice (D) 
were i.p. immunized and i.n. challenged with 
OVA (B, C, D) or PBS (A). Lungs show peri-
bronchial and perivascular accumulation of 
eosinophils in mice challenged with OVA but not 
in those challenged with PBS. Sections were 
stained with DAB in the presence of cyanide to 
reveal eosinophil peroxidase activity. Slides were 
counterstained with H&E. All pictures are at the 
same magnification (originally photographed at 
200x).  
 
 
 
Airway resistance in mutant mice 
Earlier work suggested that the peribronchial 
accumulation of eosinophils was due to local T cell 
production of the cytokines IL-4 and IL-13, which in 
turn induced epithelial production of the eosinophil 
chemokine eotaxin [28]. Since local Th2 cell produc-
tion of cytokines has also been implicated in the in-
duction of increased airway resistance [31,32], we 
also tested the mice for airway resistance changes. 
Figure 3 shows the results of airway resistance 
changes in mice as measured in a whole body 
plethysmograph. Mice were challenged with increas-
ing amounts of methylcholine, and calculated Penh 
values were used as an estimate of airway resistance. 
We found that Penh values were equally increased in 
controls, LTβ-KO, and plt mutant mice. Moreover, 
when antigen specific Th2 cells were transferred from 
wild type mice to naïve mutant mice, increases in 
airway resistance were also increased to levels exhib-
ited in wild type mice. Thus, Th2 effector responses 
leading to changes in airway resistance were also not 
dependent on either LTβ nor CCL21/CCL19. 
Antigen presenting cell recruitment in the lungs 
of mutant mice 
Antigen presenting cells or their precursors are 
generally present within nearly all tissues, presuma-
bly serving a kind of sentinel function. Inflammatory 
stimuli such as TNF and endotoxin are extremely ef-
fective in inducing resident tissue antigen presenting 
cells to become activated antigen presenting cells, 
which then migrate to draining lymph nodes to 
stimulate cellular immune responses [34]. The migra-
tion of activated antigen presenting cells to the 
draining lymph nodes is considered to be in large 
part dependent on CCL21-dependent chemotaxis 
[2,3]. In addition, while LTβ-KO mice have grossly 
normal dendritic cell subsets [5, 35], immune re-
sponses can be impaired, perhaps due in part to de-
fects in homing or recruitment of dendritic cells. Thus 
it was possible that LTβ or CCL21 deficient mice 
would show altered recruitment of antigen present-
ing cells to the lung parenchyma.   
To examine the recruitment of candidate antigen 
presenting cells, we studied the presence and distri-
bution of class II MHC positive cells within the sites 
of inflammation in the lung as previously described 
[36]. Figure 4 shows that class II MHC positive cells 
are abundant within the perivascular and peribron-
chial spaces of inflamed lung tissue in both control 
and mutant mice. In these infiltrates, eosinophils are 
also present, along with numerous CD4 T cells. 
However, while infiltrates in some immune mediated 
inflammatory diseases show spontaneous organiza-
tion into distinct T cell and B cell dependent com-
partments, allergic lung infiltrates were rather disor-
ganized. 
Next, we examined the lung infiltrates for the 
character and distribution of two main candidate an-
tigen presenting cell types: namely, B lymphocytes 
(B220 positive cells) and dendritic cells (CD11c posi-
tive cells [37,38]). As shown in Figure 5, control, 
LTβ-KO, and plt mutant mice all showed similar ac-
cumulations of B220 positive B cells and CD11c posi-
tive dendritic cells. In sum, it is clear that the recruit-
ment of both antigen presenting cell types remains 
unimpaired by the absence of LTβ and CCL21. 
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Figure 3: Airway hyper-reactivity: Twenty-four hours after the last i.n. challenge, airway responsiveness was assessed in i.p. 
immunized mice (A) and recipients of antigen specific CD4 T cell transfer (B). Airway sensitivity of C57BL/6J mice (circles), 
LTβ-KO (squares) and plt/plt mice (triangles) was tested in the presence of increasing concentration of metacholine. Mice 
challenged i.n. with OVA (black symbols) had significantly greater responsiveness to metacholine than their respective PBS 
controls (white symbols). Results are shown for 3 mice per group, representing one of two independent experiments. 
 
 
 
 
 
 
 
Figure 4: Organization of infiltrates in the lungs of asthmatic mice: Frozen lung sections from OVA challenged C57BL/6J (A, 
D), LTβ-KO (B, E) and plt/plt mice (C, F) were stained for antigen presenting cell and T cell markers. In all 3 groups of mice, 
an accumulation of CD4 T cells (A, B, C) and MHC II positive cells (D, E, F) was observed within the lung parenchyma. All 
pictures are at the same magnification (originally photographed at 200x). Int. J. Med. Sci. 2009, 6 
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Figure 5: Nature of the APCs in the lung infiltrates of asthmatic mice: C57BL/6J (A, D), LTβ-KO (B, E) and plt/plt mice (C, 
F) showed no significant differences in the type and distribution of the antigen presenting cells recruited into the inflam-
matory tissue. B220 staining revealed a strong perivascular and peribronchial accumulation of B cells (A, B, C) while dendritic 
cells (CD11c positive cells) tend to be distributed throughout the parenchyma (D, E, F). All pictures are at the same 
magnification (originally photographed at 200x). 
 
 
Discussion 
The present study was initiated to address two 
related questions on the mechanisms of immune ef-
fector responses. First, a number of chronic inflam-
matory immune responses show spontaneous or-
ganization of infiltrating lymphocytes into follicles 
with distinct T and B cell compartments, and these 
are associated with secondary lymphoid tissue factors 
LTβ and CCL21. Lung allergic inflammation might be 
considered similar in many respects to chronic in-
flammation, due to its accumulation of lymphocytic 
infiltrates and long term induction of tissue remodel-
ing. Therefore, we wanted to determine whether 
there were elements of the lung allergic inflammatory 
response that also showed dependence on LTβ and 
CCL21. Indeed, the formation of germinal centers 
within the parenchyma has been reported in inflamed 
lung after airway antigenic challenge [39]. Our results 
show that the cellular infiltrates in allergic lung in-
flammation are organized only to the extent that they 
are limited to the peribronchial and perivascular 
spaces. There is recruitment of T and B lymphocytes 
as well as dendritic cells, but there does not appear to 
be any consistent organization within the infiltrates 
themselves, suggesting that the pathogenesis of 
bronchial asthma is not dependent on germinal center 
formation. Moreover, there is no evidence that or-
ganized secondary lymphoid tissues draining the 
lung parenchyma are absolutely required; one recent 
study demonstrated that an intact spleen is sufficient 
for the generation of Th2 responses in the lung even 
in the absence of secondary lymphoid tissue (in LTα 
knockout mice [40]). Thus, allergic lung inflammation 
can be generated independently of organized secon-
dary lymphoid tissue and the associated factors LTβ 
and CCL21. 
Second, studies have suggested that chemokines 
such as CCL21 are important to the development of 
cellular immunity, as CCL21 helps in the recruitment 
of antigen presenting cells, especially dendritic cells, 
to lymphoid tissue [2,3,34] and in chronic inflamma-
tion [13]. Our results suggest that in the case of aller-
gic lung responses, CCL21 is not required for re-
cruitment of dendritic cells. It is likely that other cy-
tokines and chemokines are still important in re-
cruitment of the infiltrating cells [41], assisted by the 
induction of adhesion molecules such as ICAM-1 and 
VCAM-1. The accumulation of both T cells and anti-
gen presenting cells into the peribronchial and 
perivascular spaces may be sufficient to allow for ef-
fective local antigen presentation simply by bringing 
the cells together in a single confined compartment. 
Recent studies have also examined the ability of 
CCL21/CCL19-deficient mice to develop allergic in-
flammation [42-45], though we are not aware of simi-
lar studies on mice lacking LTβ. Initial studies on the 
CCL21/CCL19-deficient plt mouse strain had shown 
that immunologic priming showed a delayed but in 
some cases enhanced response [7], so depending on Int. J. Med. Sci. 2009, 6 
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the background strain and timing of the experimental 
protocols, one might expect to find reduced or en-
hanced responses. Indeed, in the various published 
reports, both reduced and enhanced responses have 
been reported in plt mice, leading to contradicting 
conclusions on the importance of CCL21/CCL19 
ligands in allergic inflammation. In our studies, we 
also incorporated adoptive transfer of established Th2 
cells from normal donors to show that differentiated 
effector cells showed equivalent effects on airway 
hypersensitivity regardless of the presence of 
CCL21/CCL19, or LTβ. 
Based on our results, Th2 responses appear to be 
independent of the factors associated with lymphoid 
tissues. Thus, in many cases, local Th2 responses 
could provide a default response to various immune 
triggers in the absence of strong Th1 stimuli [46]. In 
the context of mucosal “tolerance,” responses to an-
tigens presented by antigen presenting cells in the 
lung (or other mucosal tissues) may be predisposed 
toward less destructive Th2 responses instead of 
pathological Th1 responses. The development of 
pathological Th2 responses seen in allergic lung in-
flammation may further depend on additional fac-
tors, such as sporadic antigen exposure, or other fac-
tors unique to the lung anatomy.   
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